Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Topical corticosteroids are used extensively to treat inflammatory skin disorders including atopic dermatitis (AD). Several studies have described temporary reversible suppression of hypothalamic-pituitary-adrenal function. However, sound evidence of permanent disturbance of adrenal gland function is lacking. OBJECTIVES: To relate basal cortisol levels to prior use of topical corticosteroids and disease activity in patients with moderate to severe AD and to investigate the effect on basal serum cortisol levels of topical corticosteroid treatment during hospitalization. METHODS: Two groups of patients with AD were evaluated: 25 inpatients with severe AD who required hospitalization (group 1) and 28 outpatients with moderate to severe AD (group 2). In group 1, morning basal serum cortisol levels were measured twice, at admission and at discharge; in group 2, morning basal serum cortisol levels were measured once. Use of topical corticosteroids in the 3 months prior to the cortisol measurement was recorded and disease activity was monitored using the Six Area, Six Sign Atopic Dermatitis (SASSAD) score and serum thymus and activation-regulated chemokine (TARC) levels. RESULTS: On admission, basal cortisol levels in group 1 were significantly (P < 0.001) decreased in 80% of the patients. In group 2, the basal cortisol levels were normal in all but three patients. Comparing the two groups, group 1 on admission had a significantly lower cortisol level than that of group 2 (P < 0.001). Disease activity in group 1 on admission was significantly higher than that of group 2 (P < 0.001). There was no difference in use of topical corticosteroids in the 3 months before cortisol measurement. At discharge in group 1 there was a significant increase (P < 0.0001) of basal cortisol levels and a significant (P < 0.001) decrease in disease activity reflected by the decrease in serum TARC levels and SASSAD score. CONCLUSIONS: Disease activity, rather than the use of topical corticosteroids, is responsible for the low basal cortisol values in patients with severe AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.
Mastorakos, G., Chrousos, G. P., & Weber, J. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263159 · Cited by 591
Cited by
Association between Stress and the HPA Axis in the Atopic Dermatitis
Lin, T.-K., Zhong, L., & Santiago, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102131 · Cited by 127
“A decreased response from the HPA axis in AD patients is thought to result from the disease itself rather than from topical GC application [100,101].”
BackgroundLevin, E., Gupta, R., Butler, D., Chiang, C., & Koo, J. Y. M. (2014) · Journal of Dermatological Treatment · doi:10.3109/09546634.2013.844314 · Cited by 49
Buske-Kirschbaum, A., Trikojat, K., Tesch, F., Schmitt, J., Roessner, V., Luksch, H., Rösen-Wolff, A., & Plessow, F. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.12.005 · Cited by 33
Metadata
- Authors
- Haeck, I. M., Timmer-de Mik, L., Lentjes, E. G. W. M., Buskens, E., Hijnen, D. J., Guikers, C., Bruijnzeel-Koomen, C. A. F. M., & de Bruin-Weller, M. S.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05
- Volume
- 156
- Issue
- 5
- Pages
- 979-985
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2144944671
- Cited by
- 44
- References
- 1
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused. https://app.cochat.ai/papers/10.1111/j.1365-2133.2007.07753.x
- The paper
- Haeck, I. M., Timmer-de Mik, L., Lentjes, E. G. W. M., Buskens, E., Hijnen, D. J., Guikers, C., Bruijnzeel-Koomen, C. A. F. M., & de Bruin-Weller, M. S. (2007). Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.2007.07753.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.